Ray Dalio’s NeoGenomics NEO Stock Holding History

Ray Dalio’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$677K	Buy	+91,190	New	+$960K	﹤0.01%	849
2025 Q1	–	Sell	-14,397	Closed	-$237K	–	756
2024 Q4	$237K	Sell	14,397 -35,957	-71%	-$558K	﹤0.01%	661
2024 Q3	$743K	Sell	50,354 -12,374	-20%	-$194K	﹤0.01%	639
2024 Q2	$870K	Buy	62,728 +38,121	+155%	+$540K	﹤0.01%	687
2024 Q1	$387K	Sell	24,607 -5,226	-18%	-$80.7K	﹤0.01%	643
2023 Q4	$483K	Sell	29,833 -118,513	-80%	-$1.94M	﹤0.01%	707
2023 Q3	$1.82M	Buy	148,346 +21,755	+17%	+$324K	0.01%	509
2023 Q2	$2.03M	Sell	126,591 -6,836	-5%	-$113K	0.01%	456
2023 Q1	$2.32M	Buy	+133,427	New	+$1.9M	0.01%	435

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Ray Dalio's NEO Position: Q1 2026 in Review

Ray Dalio opened a new position in NeoGenomics (NEO) in Q1 2026: 91,190 shares worth $677K. The stake represents ﹤0.01% of the portfolio and ranks #849 among its holdings. This is a return to the name: Ray Dalio previously reported a position in NEO as recently as Q4 2024.

Ray Dalio first reported a position in NEO in Q1 2023 and has held it in 9 quarters since. The position peaked at $2.32M in Q1 2023. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

Ray Dalio held 91,190 shares of NeoGenomics worth $677K as of Q1 2026.
NeoGenomics was a new Ray Dalio position in Q1 2026.
NeoGenomics made up ﹤0.01% of Ray Dalio's portfolio in Q1 2026, its #849 holding.
Ray Dalio first reported a position in NeoGenomics in Q1 2023 and has held it in 9 quarters since.
Ray Dalio's NeoGenomics position peaked at $2.32M in Q1 2023.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.